Kynos Therapeutics

Kinaset Therapeutics

This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.

Thrasos

This biotherapeutics company develops targeted peptide therapies for the prevention and treatment of kidney diseases for patients with acute and chronic renal conditions.

Kynexis

This clinical-stage biotechnology company develops precision therapeutics and small-molecule inhibitors to treat cognitive impairment in patients with schizophrenia and other neurological disorders.

Inotrem

This biopharmaceutical company develops immunotherapies targeting the TREM-1 pathway for patients suffering from acute inflammatory syndromes such as septic shock.

Sudo Biosciences

This biopharmaceutical company develops precision tyrosine kinase 2 inhibitors for patients with serious neurological and immune-mediated inflammatory conditions.

GenKyoTex

This biopharmaceutical company develops selective NOX inhibitors to treat patients with chronic inflammatory and fibrotic diseases such as primary biliary cholangitis.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.